Track topics on Twitter Track topics that are important to you
The NOK 50.4mm deal includes a rename of the business unit to Ultimovacs AB
Norway's Ultimovacs plans to raise around 700 million Norwegian crowns ($82 million) in an initial public offering in early 2019 to help fund the development of its immunotherapy cancer drug.
Norway biotech Ultimovacs plans IPO to develop cancer drug https://reut.rs/2RwH1ws
Ultimovacs AS ('Ultimovacs') was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to m...
We have published hundreds of Ultimovacs AS news stories on BioPortfolio along with dozens of Ultimovacs AS Clinical Trials and PubMed Articles about Ultimovacs AS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ultimovacs AS Companies in our database. You can also find out about relevant Ultimovacs AS Drugs and Medications on this site too.
Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers) - Mouth cancer can develop on the lip, the tongue, the floor...
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...